Skip to content

Research on the Improvement of Femoral Vein Catheter Care for Reducing Femoral Vein Catheter-related Complications in Patients Undergoing Artificial Liver Therapy

Research on the Improvement of Femoral Vein Catheter Care for Reducing Femoral Vein Catheter-related Complications in Patients Undergoing Artificial Liver Therapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600120335
Enrollment
Unknown
Registered
2026-03-12
Start date
2026-03-17
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

complications related to femoral vein catheterization, including catheter-related bloodstream infection (CRBSI), puncture site oozing, subcutaneous hematoma, catheter-related venous thrombosis, catheter displacement or dislodgement, catheter occlusion, and medical adhesive-related skin injury (MARSI).

Interventions

Modified nursing group:N/A
routine nursing group:N/A

Sponsors

The Ninth Hospital of Nanchang City
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Cases of patients undergoing artificial liver therapy with indwelling femoral vein catheters; 2.Indwelling femoral vein catheter for >= 10 days; 3.Inpatients treated in our hospital;

Exclusion criteria

Exclusion criteria: 1.Cases of patients undergoing artificial liver therapy with an indwelling femoral vein catheter for < 10 days; 2.Patients with pre-existing infection before catheterization; 3.Patients with severe underlying diseases such as cardiac, pulmonary, and cerebrovascular diseases, or those who are unable to cooperate; 4.Patients complicated with coagulation system diseases; 5.Patients with mental illnesses who are unable to cooperate; 6.Patients with indwelling femoral vein catheters transferred from other hospitals;

Design outcomes

Primary

MeasureTime frame
Catheter-related venous thrombosis;Puncture site oozing?Hematoma;including catheter-related bloodstream infection (CRBSI);medical adhesive-related skin injury (MARSI);

Countries

China

Contacts

Public ContactZhang Zhen

The Ninth Hospital of Nanchang City

420620519@qq.com+86 791 8849 9522

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026